Liangzhi Xie Selected Research

Liangzhi Xie Research Topics

Disease

13	COVID-19 05/2024 - 01/2020
3	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 10/2022
3	Neoplasms (Cancer) 11/2023 - 01/2023
3	Virus Diseases (Viral Diseases) 12/2020 - 12/2002
2	Infections 01/2023 - 01/2017
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2022 - 04/2016
2	Hemorrhage 11/2022 - 09/2021
2	Communicable Diseases (Infectious Diseases) 09/2022 - 05/2022
2	Disease Progression 01/2022 - 01/2011
1	Weight Loss (Weight Reduction) 05/2024
1	Sarcoma (Soft Tissue Sarcoma) 12/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023
1	Melanoma (Melanoma, Malignant) 11/2023
1	Colonic Neoplasms (Colon Cancer) 11/2023
1	Bell Palsy (Bell's Palsy) 10/2023
1	Pneumonia (Pneumonitis) 02/2023
1	Inflammation (Inflammations) 01/2023
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2022
1	Hemophilia A (Haemophilia) 11/2022
1	Breakthrough Infections 11/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2022
1	Esophageal Squamous Cell Carcinoma 01/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022
1	Ebola Hemorrhagic Fever 01/2017

Drug/Important Bio-Agent (IBA)

9	Monoclonal AntibodiesIBA 01/2024 - 04/2016
6	VaccinesIBA 02/2023 - 01/2020
4	Neutralizing AntibodiesIBA 01/2023 - 01/2011
3	AntibodiesIBA 05/2024 - 01/2017
2	ErbB Receptors (EGF Receptor)IBA 12/2023 - 10/2022
2	SCTV01C vaccineIBA 10/2023 - 01/2023
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2023 - 01/2023
2	Biosimilar PharmaceuticalsIBA 06/2023 - 11/2022
2	COVID-19 VaccinesIBA 01/2023 - 01/2022
2	Rituximab (Mabthera)FDA Link 12/2022 - 12/2022
1	IgYIBA 05/2024
1	Fluorouracil (Carac)FDA LinkGeneric 01/2024
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2024
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2024
1	Therapeutic UsesIBA 11/2023
1	Interferon-betaIBA 11/2023
1	InterferonsIBA 11/2023
1	Immune Checkpoint InhibitorsIBA 11/2023
1	Bevacizumab (Avastin)FDA Link 06/2023
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2023
1	Factor VIII (Coagulation Factor VIII)IBA 11/2022
1	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 11/2022
1	Adalimumab (Humira)FDA Link 11/2022
1	NanovaccinesIBA 05/2022
1	Polysaccharides (Glycans)IBA 05/2022
1	Growth Factor ReceptorsIBA 01/2022
1	Single-Domain AntibodiesIBA 01/2022
1	upanovimabIBA 10/2021
1	AntigensIBA 01/2021
1	Angiotensin-Converting Enzyme 2IBA 12/2020
1	Proteins (Proteins, Gene)FDA Link 12/2020
1	Glycoproteins (Glycoprotein)IBA 01/2017
1	Surface-Active Agents (Surfactants)IBA 07/2003
1	BuffersIBA 07/2003
1	Glucose (Dextrose)FDA LinkGeneric 12/2002
1	Glutamine (L-Glutamine)FDA Link 12/2002
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2002

Therapy/Procedure

8	Therapeutics 05/2024 - 01/2020
2	Injections 11/2022 - 09/2021
2	Intravenous Infusions 09/2022 - 01/2022
1	Immunotherapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2022